Loading...

AUTL AUTOLUS THERAPEUTICS PLC Earnings Reports 8-K Filing

TLS

TL

AUTOLUS THERAPEUTICS PLC

(AUTL)

2026 8-K

Financial Results Update

New Agreement Signed

Financial Update

Director Appointment

Financial Update

Annual Report and AGM Notice

Financial Statements

Investor Update

Management Changes

Financial Results

Corporate Update

Financial Results

Corporate Update

Management Change

Lease Amendment

Financial Results and Corpo...

Financial Statements and Ex...

Clinical Study Data Announc...

Financial Results and Corpo...

Rescheduled Conference Call...

Management Changes

Accounting Error

Conference Call Transcript

Financial Results and Manag...

Corporate Presentation

Underwriting Agreement

License and Option Agreemen...

FDA Accepts BLA for obecabt...

Appointment of New Director

Management Changes

ASH Annual Meeting Presenta...

Regulation FD Disclosure

External Links:

On January 12, 2026, Autolus Therapeutics plc reported preliminary 2025 net product revenue of approximately $24 million for Q4 and $75 million for the full year, projecting 2026 revenue between $120 million and $135 million, with sufficient funds projected to last into Q4 2027.

AI Assistant

AUTOLUS THERAPEUTICS PLC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.